Do You want daily job updates ?

Do You want daily job updates ?
Click here and enter your mail id.

Wednesday 28 September 2016

Topping the list of the Asian pharma elite is India's Dilip Shanghvi, who founded Sun Pharmaceuticals along with partner Pradeep Ghosh in 1982. The company's acquisitions of Caraco Pharma, Taro Pharma and, more recently, fellow Indian company Ranbaxy Laboratories have made Sun Pharma into India's largest drugmaker.
Shanghvi stepped down as chairman and CEO of the company in 2012, but he remains managing director, as well as chairman of Sun Pharmaceutical Advanced Research, which is spearheading the group's push into proprietary medicines. His $16.7 billion fortune ranks him at number 44 in the overall Forbes list.
Image result for sun pharma
In second position among Asia's pharma rich is Cyrus Poonawalla, chairman of the Poonawalla Group, which includes Serum Institute of India, India's largest biotech company, which specializes in manufacturing pediatric vaccines.

Poonawalla set up Serum Institute of India in 1966, at a time when lifesaving vaccines were in short supply in India, and those were imported at high prices. The company has since grown to become the world's largest vaccine producer in terms of the number of doses produced and sold globally. With a net worth of $8.5 billion, Poonawalla sits at position 133 in the Forbes list.

source:http://www.fiercepharma.com/pharma-asia/sun-pharma-s-dilip-shanghvi-heads-list-top-asian-pharma-billionaires
www.CareerBiotech.com. Powered by Blogger.